Cargando…

Phosphodiesterase 4 inhibitor apremilast improves insulin resistance in psoriasis patients

Detalles Bibliográficos
Autores principales: Ikumi, Kyoko, Torii, Kan, Sagawa, Yoko, Kanayama, Yoshifumi, Nakada, Aya, Nishihara, Haruna, Morita, Akimichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304264/
https://www.ncbi.nlm.nih.gov/pubmed/34961971
http://dx.doi.org/10.1111/1346-8138.16286
_version_ 1784752064239239168
author Ikumi, Kyoko
Torii, Kan
Sagawa, Yoko
Kanayama, Yoshifumi
Nakada, Aya
Nishihara, Haruna
Morita, Akimichi
author_facet Ikumi, Kyoko
Torii, Kan
Sagawa, Yoko
Kanayama, Yoshifumi
Nakada, Aya
Nishihara, Haruna
Morita, Akimichi
author_sort Ikumi, Kyoko
collection PubMed
description
format Online
Article
Text
id pubmed-9304264
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93042642022-07-28 Phosphodiesterase 4 inhibitor apremilast improves insulin resistance in psoriasis patients Ikumi, Kyoko Torii, Kan Sagawa, Yoko Kanayama, Yoshifumi Nakada, Aya Nishihara, Haruna Morita, Akimichi J Dermatol Letters to the Editor John Wiley and Sons Inc. 2021-12-27 2022-04 /pmc/articles/PMC9304264/ /pubmed/34961971 http://dx.doi.org/10.1111/1346-8138.16286 Text en © 2021 The Authors. The Journal of Dermatology published by John Wiley & Sons Australia, Ltd on behalf of Japanese Dermatological Association https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Letters to the Editor
Ikumi, Kyoko
Torii, Kan
Sagawa, Yoko
Kanayama, Yoshifumi
Nakada, Aya
Nishihara, Haruna
Morita, Akimichi
Phosphodiesterase 4 inhibitor apremilast improves insulin resistance in psoriasis patients
title Phosphodiesterase 4 inhibitor apremilast improves insulin resistance in psoriasis patients
title_full Phosphodiesterase 4 inhibitor apremilast improves insulin resistance in psoriasis patients
title_fullStr Phosphodiesterase 4 inhibitor apremilast improves insulin resistance in psoriasis patients
title_full_unstemmed Phosphodiesterase 4 inhibitor apremilast improves insulin resistance in psoriasis patients
title_short Phosphodiesterase 4 inhibitor apremilast improves insulin resistance in psoriasis patients
title_sort phosphodiesterase 4 inhibitor apremilast improves insulin resistance in psoriasis patients
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304264/
https://www.ncbi.nlm.nih.gov/pubmed/34961971
http://dx.doi.org/10.1111/1346-8138.16286
work_keys_str_mv AT ikumikyoko phosphodiesterase4inhibitorapremilastimprovesinsulinresistanceinpsoriasispatients
AT toriikan phosphodiesterase4inhibitorapremilastimprovesinsulinresistanceinpsoriasispatients
AT sagawayoko phosphodiesterase4inhibitorapremilastimprovesinsulinresistanceinpsoriasispatients
AT kanayamayoshifumi phosphodiesterase4inhibitorapremilastimprovesinsulinresistanceinpsoriasispatients
AT nakadaaya phosphodiesterase4inhibitorapremilastimprovesinsulinresistanceinpsoriasispatients
AT nishiharaharuna phosphodiesterase4inhibitorapremilastimprovesinsulinresistanceinpsoriasispatients
AT moritaakimichi phosphodiesterase4inhibitorapremilastimprovesinsulinresistanceinpsoriasispatients